Table 2 COVID-19-related disruptions to measles burden and vaccination impact. Total burden (cases, deaths, and DALYs) and vaccine impact (cases, deaths, and DALYs averted) in ten high measles burden countries over 2000–2050 are presented, based on coverage estimates without and with disruptions caused by COVID-19. Proportionate changes due to COVID-19 disruptions are shown in parentheses. Model scenarios in this analysis were conducted under the ‘full-update’ model, with the assumption of R0 = 16 and implementation of MCV1, MCV2, and SIA. Abbreviations: DALY disability-adjusted life years, MCV1 first routine dose of measles-containing vaccine, MCV2 second routine dose of measles-containing vaccine, SIA supplementary immunisation activity
|  | Measles burden over 2000–2050 | Vaccine impact over 2000–2050 | |||
|---|---|---|---|---|---|
Measurements (millions) | Non-COVID-19 scenario | COVID-19 scenario | Additional burden due to COVID-19 | Non-COVID-19 scenario | COVID-19 scenario |
Cases | 253.43 (ref) | 260.56 (+ 2.81%) | 7.12 | 2243.81 (ref) | 2236.69 (− 0.32%) |
Deaths | 3.76 (ref) | 3.86 (+ 2.90%) | 0.109 | 42.64 (ref) | 42.53 (− 0.26%) |
DALYs | 233.43 (ref) | 240.13 (+ 2.87%) | 6.70 | 2797.73 (ref) | 2791.03 (− 0.24%) |